S A Piha-Paul
Overview
Explore the profile of S A Piha-Paul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
497
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Janku F, Huang H, Fujii T, Shelton D, Madwani K, Fu S, et al.
Ann Oncol
. 2016 Dec;
28(3):642-650.
PMID: 27993791
Background: Cell-free DNA (cfDNA) from plasma offers easily obtainable material for KRAS mutation analysis. Novel, multiplex, and accurate diagnostic systems using small amounts of DNA are needed to further the...
12.
Liu X, George G, Tsimberidou A, Naing A, Wheler J, Kopetz S, et al.
BMC Cancer
. 2015 Oct;
15:713.
PMID: 26474549
Background: This retrospective study aims to investigate the activity of retreatment with anti-EGFR-based therapies in order to explore the concept of clonal evolution by evaluating the impact of prior activity...
13.
Piha-Paul S, Munster P, Hollebecque A, Argiles G, Dajani O, Cheng J, et al.
Eur J Cancer
. 2015 Jul;
51(14):1865-73.
PMID: 26199039
Background: The phosphatidylinositol 3-kinase/protein kinase-B/mammalian target of rapamycin (PI3K-AKT-mTOR) signalling pathway is aberrantly activated in several cancers. Notch signalling maintains cell proliferation, growth and metabolism in part by driving the...
14.
Wheler J, Falchook G, Tsimberidou A, Hong D, Naing A, Piha-Paul S, et al.
Ann Oncol
. 2012 Nov;
24(3):838-42.
PMID: 23139256
Background: Epidermal growth factor receptor (EGFR) mutations are associated with the response to EGFR inhibitors in patients with non-small-cell lung cancer (NSCLC). We sought to investigate EGFR aberrations in patients...